<DOC>
	<DOCNO>NCT01089855</DOCNO>
	<brief_summary>The trial design evaluate efficacy tolerability carbamazepine neuropathic pain diabetic patient</brief_summary>
	<brief_title>Efficacy Tolerability Carbamazepine CR Diabetic Neuropathy Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Diabetes patient Diabetes neuropathy DN4 &gt; equal 4 Male female age 21 65 year Informed consent HbA1C &lt; 11 % Prior Hospitalization Acido cetosis Prior hospitalization severe hypoglycemia Pregnancy Hepatitis Diabetes foot AVB ( auriculoventricular conduction disturbance ) Patient treat antidepressant drug Patient treat antiepileptic drug Patients blood ion disturbance Patient neutropenia Glaucoma Bladder Adenoma Alcohol abuse Creatinin clearance &lt; 60 ml/ minute Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Brief Pain Inventory</keyword>
	<keyword>DN4 questionnaire</keyword>
	<keyword>ElectroCardioGram</keyword>
</DOC>